Stock Market Analysis & Opinion

Danish biotech company Zealand Pharma is an 'R&D shop' focused on developing new drugs, including promising weight loss compounds in the pipeline. Zealand Pharma differs from most other companies,...

China’s latest stimulus package is sparking optimism among investors. Key Chinese companies are already seeing gains, with more upside potential in focus. Below, we'll take a look at three stocks...

Stocks on Wall Street are rallying, with the S&P 500 hitting a series of new record highs recently. Identifying strong-buy momentum stocks with solid growth prospects becomes paramount in the...

Boeing (NYSE:BA) faces mounting pressure as its largest union rejected the company’s “best and final” offer, prolonging a strike that has already lasted nearly two weeks. The labor dispute comes amid...

Following the 50 bps rate cut on September 18th, the Nasdaq Composite (IXIC) is up 1.47%. The technology-oriented index mirrors investor expectations that cheaper capital will aid capital-intensive...

The US government plans to ban the import and sale of cars with certain Chinese or Russian IT technology. Systems for autonomous driving and digital communication systems are particularly affected,...

Global stocks are pointing higher on Tuesday morning as a boost from China improves sentiment. A benchmark of Chinese stocks was up over 5.5% after People's Bank of China (PBOC) Governor Pan...

Today, I reviewed earnings for various companies and will use the underwhelming session to highlight why earnings and fundamentals matter despite some believing they don’t. Concerns are mounting over...

For years, the U.S. has been the dominant player in military spending, with American companies like Lockheed Martin (NYSE:LMT) and Rtx Corp (NYSE:RTX) (formerly Raytheon) commanding the global arms...

Danish biotech company Gubra has skyrocketed in 2024 and is suddenly on the radar of many retail investors. Since its listing on Nasdaq Copenhagen at a price of 110 kr. in March 2023, the share price...

As conference season continues, investors should consider guidance offered at other corporate event types too Analyst & Capital Markets Days often feature important business strategy updates...

Molten Ventures has already surpassed its £100m realisation target for FY25 (ending March 2025) with exits from Perkbox, Endomag, Graphcore and M-Files, which in aggregate represent £124m in exit...

Embracing patience in investing can significantly enhance your chances of long-term success. A simple strategy of holding investments for 10 to 15 years yields impressive odds of...

Over the last week or so, I have seen quite a few comments about the S&P 500 such as the ones below: "We could hit 10k sometime around 2028 but I wouldn't be surprised with 2027 either." "At...